Myocardial infarction in young adults

Postgraduate Medical Journal

Volumn 81, Issue 962, 2005, Pages 741-745

  Egred, M ^a   Viswanathan, G ^b   Davis, G K ^b  

^a LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; COCAINE; DIAMORPHINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT; HEART ENZYME; ILLICIT DRUG; NICOTINIC ACID; NITRATE; OMEGA 3 FATTY ACID; STATINE DERIVATIVE; VITAMIN B COMPLEX;

ADULT; AGE; ANAMNESIS; ANGIOCARDIOGRAPHY; ANTIPHOSPHOLIPID SYNDROME; ATHEROSCLEROTIC PLAQUE; CLINICAL FEATURE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DISEASE COURSE; DRUG MISUSE; FINANCIAL MANAGEMENT; HEART INFARCTION; HUMAN; HYPERCOAGULABILITY; INCIDENCE; MORBIDITY; NEPHROTIC SYNDROME; PERCUTANEOUS CORONARY INTERVENTION; PSYCHOLOGICAL ASPECT; REVIEW; RISK FACTOR; SYMPTOM; THORAX PAIN;

ADULT; ANGINA PECTORIS; BLOOD COAGULATION DISORDERS; CORONARY ARTERIOSCLEROSIS; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; SUBSTANCE-RELATED DISORDERS;

EID: 29244446774     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.2004.027532     Document Type: Review

References (67)

1. Department of Health. National Service Framework for Coronary Heart Disease, 2000. http://www.doh.gov.uk/publications.
2. Office of National Statistics. Indicators of the nation's health-ischaemic heart disease: male and female death rates by special causes, 2002. http://www.statistics.gov.uk/mortality.
3. Office of National Statistics. Weekly incidence of heart attacks http://www.statistics.gov.uk/morbidity/cardiovascular diseases.
4. Sinha R, Fisch G, Teague B, et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002;346:802-10.
5. Office of National Statistics. Key health statistics from General Office, 2000. http://www.statistics.gov.uk/health and care.
6. Klein LW, Nathan S. Coronary artery disease in young adults. J Am Coll Cardiol 2003;41:529-31.
7. Jaloweil DA, Hill JA. Myocardial infarction in young men and women. Cardiovasc Clin 1989;20:197-206.
8. Department of Health. Drug use, smoking and drinking among young people in England in 2001. http://www.doh.gov.uk/publication/publication statistics.
9. British Heart Foundation. BHF coronary heart disease statistics 2003. http://www.bhf.org.uk/professionals/statistics.
10. Ebbeling CB, Pawlak BB, Ludwig DS. Lancet 2002;360:473-82.
11. Horton R. Who pays in the obesity war? Lancet 2003;363:339.
12. Curren PJ, Chung EH, Chauhan MS. Metabolic syndrome: an under recognized risk factor for myocardial infarction in the young. (Abstract). J Am Coll Cardiol 2004;43:249A.
13. Bhatnagar D, Anand IS, Durrington PN, et al. Coronary risk factors in people from Indian sub-continent living in West London and their siblings in India. Lancet 1995;345:404-9.
14. Enas EA, Mehta JL. Malignant coronary artery disease in young Asian Indians: thoughts on pathogenesis, prevention and treatment. Clin Cardiol 1995;18:131-5.
15. Jay SJ, Hollander JE. Cocaine use and chest pain syndromes. Arch Intern Med 1998;158:1827-8.
16. Office of National statistics Drug abuse, misuse of alcohol and smoking. http://www.statistics.gov.uk/cci.
17. McGill HC Jr, McMahan CA, Zieske AW, et al. Association of coronary heart disease risk Factors with microscopic qualities of coronary atherosclerosis in youth. Circulation 2000;102:374.
18. Milonig G, Malcolm GT, Wick G. Early inflammatory and immunological lesions in juvenile atherosclerosis from the pathological determinants of atherosclerosis in youth (PDAY) study. Atherosclerosis 2002;160:444-8.
19. Berenson GS, Srinivasan SR, Bao W, et al. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults: the Bogalusa heart study. N Engl J Med 1998;338:1650-6.
20. Zimmerman FH, Cameron A, Fisher LD, et al. Myocardial infarction in young adults: Angiographic characteristics, risk factors and prognosis, coronary artery surgery study register (CASS). J Am Coll Cardiol 1995;26:654.
21. Mukherjee D, Hsu A, Moliterno DJ, et al. Risk factors for premature coronary artery disease and determinants of adverse outcomes after revascularisation in patients less than 40 years old. Am J Cardiol 2003;92:1465-7.
22. Chen L, Chester M, Kaski JC. Clinical factors and angiographic features associated with premature coronary artery disease. Chest 1995;108:364.
23. Gaeta G, de Michale M, Cuomo S, et al. Arterial abnormalities in the offspring of patients with premature myocardial infarction. N Engl J Med 2000;343:840-6.
24. Malmberg K, Barenholm P, Hamsten A. Clinical and biochemical factors associated with prognosis after myocardial infarction at a younger age. J Am Coll Cardiol 1994;24:592-4.
25. Foody JM, Milberg JA, Robinson K, et al. Homocysteine and lipoprotein (a) interact to increase coronary artery disease risk in young men and women. Arteriosclerosis Throm Vasc Biol 2000;20:493-9.
26. Issar HS, Puri VK, Narain VS, et al. Lipoprotein (a) and lipid levels in young patients with myocardial infarction and in their first degree relatives. Indian Heart J 2001;53:463-6.
27. Iribarren C, Sydney S, Bild DE, et al. Association of hostility with coronary artery calcification in young adults; the CARDIA study. Coronary artery risk determinants in young adults. JAMA 2000;283:2546-51.
28. Klues HG, Schwartz ER, Vom Dahl S, et al. Disturbed intra coronary heamodynamics myocardial bridging: early normalisation by intra coronary stent placement. Circulation 1997;96:2905-13.
29. Stables RH, Knight CJ, McNeill JG, et al. Coronary stenting in the management of myocardial ischaemia caused by muscle bridging. Br Heart J 1995;74:90-2.
30. Möhlenkamp S, Hort W, Ge J, et al. Update on myocardial bridging. Circulation 2006;106:2616.
31. Vale PR, Baron DW. Coronary artery stenting for spontaneous coronary artery dissection: a case report and review or literature. Cathet Cardiovas Diagn 1998;45:280-6.
32. Butler R, Webster MWI, Davies GK, et al. Spontaneous dissection of native coronary arteries. Heart 2005;91:223-4.
33. Mathew J, Addai T, Anand A. Clinical features, site of involvement, bacteriological findings and outcomes of infective endocarditis in intra venous drug users. Arch Intern Med 1995;155:1641-6.
34. Valtonen V, Kuikka A, Syrjanen J. Thromboembolic complication in bacteremic infections Eur Heart J 1993;14(suppl K):20-3.
35. Dagalp Z, Pamir G, Alpman A, et al. Coronary artery aneurysms. Report of two cases and review of literature. Angiology 1996;47:197-201.
36. Egred M, Patel JC, Walton S. Impending paradoxical embolism. Circulation 2001;103:113-14e.
37. Egred M, Patel JC, Walton S. Management of paradoxical coronary embolism. Circulation 2001;104:153e.
38. Hollander JE, Todd KH, Green G, et al. Chest pain associated with cocaine: an assessment of prevalence in suburban and urban emergency departments. Ann Emerg Med 1995;26:671-6.
39. Lange RA, Hills CD. Cardiovascular complications of cocaine use. N Engl J Med 2001;345:351-8.
40. Kolodgie KD, Virmani R, Cornhill JF, et al. Increase in atherosclerosis and adventitial cell mass in cocaine abusers-an alternative mechanism of cocaine associated coronary vosospasm and thrombosis. J Am Coll Cardiol 1991;17:1553-60.
41. Gitter MJ, Goldsmith SR, Duntar DN, et al. Cocaine and chest pain: clinical features and outcomes of the patients hospitalised to rule out myocardial infarction. Ann Intern Med 1991;115:277-82.
42. Hollander JE, Levitt MA, Young GP, et al. Effect of recent cocaine use on the specificity of cardiac markers for diagnosis of acute myocardial infarction. Am Heart J 1998;135:245-52.
43. Ghuran A, van Der Wieken LR, Nolan J. Cardiovascular complications of recreational drugs. BMJ 2001;323:464-6.
44. Gowda RM, Khan IA, Vasavada BC, et al. Alcohol-triggered acute myocardial infarction. Am J Ther 2003;10:71-2.
45. Jouhikainen T, Pohjola-Sintonen S, Stephansson E. Lupus anticoagulant and cardiac manifestation in systemic lupus erythematosus. Lupus 1994;3:167.
46. Harats D, George J, Levy Y, et al. Atheroma links with an antiphospholipid antibodies: Hughes syndrome and lupus. Q J Med 1999;92:57-9.
47. Vaarala O. Antiphospholipid antibodies and athrtrosclerosis. Lupus 1996;5:442-7.
48. Quismorio FP Jr. Clinical application of serological abnormalities in systemic lupus erythematoses. In: Wallace DJ, Hahn BH, eds. Dubois' lupus erythematoses. 5th ed. Baltimore: William and Wilkins, 1997:925-42.
49. Osula S, Bell GM, Hornung RS. Acute myocardial infarction in young adults: causes and management. Postgrad Med J 2002;78:27-31.
50. Tanis K, Bloemankamp DG, Van Den Bosch MA, et al. Prothrombotic coagulation defects and cardiovascular risk factors in young women with acute myocardial infarction. Br J Haematol 2003;1:471.
51. Petitti DB. Combination estrogen-progestin oral contraceptives. N Engl J Med 2003;349:1443-50.
52. Klein LW, Agarwal JB, Herlich MB, et al. Prognosis of symptomatic coronary artery disease in young adults aged 40 years or less. Am J Cardiol 1987;60:1269-72.
53. Schamroth L. Pericarditis. In: An introduction to electro cardiography. 7th ed. Oxford: Oxford University Press, 1990:189-95.
54. Chouhan L, Hajan HA, Pomposiello JC. Comparision of thrombolytics therapy for acute myocardial infarction in patients aged less than 35 and, more than 55 years. Am J Cardiol 1993;71:157.
55. Cole JH, Miller III JI, Sperling LS, et al. Long-term follow-up of coronary artery disease presenting in young adults. J Am Coll Cardiol 2003;41:521-8.
56. Fournier JA, Sanchez A, Quero J, et al. Myocardial infarction in men aged 40 years or less: a prospective clinical angiographic study. Clin Cardiol 1996;19:531-6.
57. Mehan VK, Urben P, Dornez PA, et al. Coronary angioplasty in the young-procedural results and later outcome. J Invasive Cardiol 1994;6:202.
58. Ng WK, Vedder M, Whitlock RM, et al. Coronary revascularisation in young adults. Eur J Cardiothorac Surg 1997;11:732.
59. Floten HS, Ahmed A, Swanson JS, et al. Long term survival after post infarction bypass operation, early and late operation. Ann Thorac Surg 1989;48:757.
60. Schafer AI, Levine MN, Konkle BA, et al. Thrombotic disorders: diagnosis and treatment. Hematology 2003;520-39.
61. Miller M. Niacin as a component of combination therapy for dyslipidaemia. Mayo Clin Proc 2003;78:735-42.
62. Din JN, Newby DE, Flapan AD. Omega 3 fatty acids and cardiovascular disease-fishing for a natural treatment. BMJ 2004;328:30-5.
63. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 1998;338:1042-50.
64. The Heart Outcomes Prevention Evaluation study investigators. Effects of angiotensin converting enzyme inhibitor ramipril on cardiovascular events in high-risk patients. N Engl J Med 2000;342:145-53.
65. The EUROpean trial on reduction of cardiac events with perindopril in stable coronary artery disease envestigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised double blind, placebo controlled, multicentre trial (the EUROPA study). Lancet 2003;362:782-8.
66. Moccetti T, Malacrida R, Pasotti E, et al. Epidemiologic variables and outcome of 1972 young patients with acute myocardial infarction. Data from GISSI-2 database. Investigators of the Gruppo Italiano per lo Studio della Soprawienza nell'Infarto Miocardico (GISSI-2). Arch Intern Med 1997;157:865.
67. Porter A, Wurzel M, Ben-Gal T, et al. Long term prognosis of 210 patients who underwent coronary angiography before 40 years of age. Am J Cardiol 1998;81:1168.